Status:
UNKNOWN
Artificial Intelligence System Based on Raman Spectroscopy in Inflammatory Bowel Disease
Lead Sponsor:
Changi General Hospital
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
21-90 years
Phase:
NA
Brief Summary
Inflammatory bowel diseases (IBD) are chronic inflammatory disorders that can be categorized as ulcerative colitis (UC), Crohn's disease (CD) and indeterminate colitis (IC). Deep remission has been sh...
Detailed Description
1\. BACKGROUND AND RATIONALE Inflammatory bowel diseases (IBD) are chronic inflammatory disorders that can be categorized as ulcerative colitis (UC), Crohn's disease (CD) and indeterminate colitis (IC...
Eligibility Criteria
Inclusion
- Known or suspected diagnosis of ulcerative colitis or Crohn's disease
- Age 21 to 90 years (selected age range based on demographic of patients managed at Changi General Hospital)
- Ability to provide informed consent
Exclusion
- Presence of significant coagulopathy that precludes endoscopic biopsies
- Refusal to provide consent
- Pregnant subjects
- Incarcerated status
Key Trial Info
Start Date :
April 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04888299
Start Date
April 14 2021
End Date
April 1 2023
Last Update
May 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changi General Hospital
Singapore, Singapore, 529889